DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DAYTRANA

« Back to Dashboard

Clinical Trials for Daytrana

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00434213	Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA	Completed	Noven Therapeutics	Phase 4	This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
NCT00499863	Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD	Completed	Noven Therapeutics	Phase 3	To assess the efficacy and safety of efficacy of MTS compared to placebo
NCT00501293	Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD	Completed	Noven Therapeutics	Phase 3	To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD
NCT00506285	Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD	Completed	Shire	Phase 3	This study will look at the effectiveness of Methylphenidate Transdermal System (MTS) in treating adult ADHD. MTS has received FDA approval for childhood ADHD but this is the first trial for adult ADHD. Subjects will experience two screening visits and one baseline visit. Those who meet admission criteria will enter the double-blind phase. This will involve two 4-week treatment periods one of which will involve the use of MTS and the other a placebo patch. Subjects who complete the double-blind phase will be allowed to enter a 180-day, open-label MTS phase designed to assess long-term effects.

Clinical Trial Conditions for Daytrana

Condition Name

Condition Name for Daytrana
Intervention	Trials
Attention Deficit Hyperactivity Disorder	7
ADHD	3
Delayed Emergence From Anesthesia	1
Accidental Falls	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Daytrana
Intervention	Trials
Attention Deficit Disorder with Hyperactivity	11
Hyperkinesis	8
Problem Behavior	1
Delayed Emergence from Anesthesia	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Daytrana

Trials by Country

Trials by Country for Daytrana
Location	Trials
United States	68

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Daytrana
Location	Trials
Virginia	4
Ohio	4
Kentucky	3
Arizona	3
California	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Daytrana

Clinical Trial Phase

Clinical Trial Phase for Daytrana
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	4
Phase 1	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Daytrana
Clinical Trial Phase	Trials
Completed	9
Recruiting	2
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Daytrana

Sponsor Name

Sponsor Name for Daytrana
Sponsor	Trials
Noven Therapeutics	3
Shire	2
Massachusetts General Hospital	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Daytrana
Sponsor	Trials
Other	11
Industry	5
NIH	1

Export unavailable in trial.
Subscribe for complete access.